These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27834774)

  • 1. Five-Year Longitudinal Brain Volume Change in Healthy Elders at Genetic Risk for Alzheimer's Disease.
    Reiter K; Nielson KA; Durgerian S; Woodard JL; Smith JC; Seidenberg M; Kelly DA; Rao SM
    J Alzheimers Dis; 2017; 55(4):1363-1377. PubMed ID: 27834774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease genetic risk and changes in brain atrophy and white matter hyperintensities in cognitively unimpaired adults.
    Soldan A; Wang J; Pettigrew C; Davatzikos C; Erus G; Hohman TJ; Dumitrescu L; Bilgel M; Resnick SM; Rivera-Rivera LA; Langhough R; Johnson SC; Benzinger T; Morris JC; Laws SM; Fripp J; Masters CL; Albert MS
    Brain Commun; 2024; 6(5):fcae276. PubMed ID: 39229494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders.
    Rao SM; Bonner-Jackson A; Nielson KA; Seidenberg M; Smith JC; Woodard JL; Durgerian S
    Neuroimage; 2015 May; 111():136-46. PubMed ID: 25687593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
    Soares JZ; Pettersen R; Benth JŠ; Persson K; Strobel C; Selbæk G; Bogdanovic N
    J Alzheimers Dis; 2021; 79(1):311-321. PubMed ID: 33252081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
    Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
    JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.
    Khan W; Giampietro V; Banaschewski T; Barker GJ; Bokde AL; Büchel C; Conrod P; Flor H; Frouin V; Garavan H; Gowland P; Heinz A; Ittermann B; Lemaître H; Nees F; Paus T; Pausova Z; Rietschel M; Smolka MN; Ströhle A; Gallinat J; Vellas B; Soininen H; Kloszewska I; Tsolaki M; Mecocci P; Spenger C; Villemagne VL; Masters CL; Muehlboeck JS; Bäckman L; Fratiglioni L; Kalpouzos G; Wahlund LO; Schumann G; Lovestone S; Williams SC; Westman E; Simmons A; ; ;
    J Alzheimers Dis; 2017; 56(3):1159-1174. PubMed ID: 28157104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    Konishi K; Joober R; Poirier J; MacDonald K; Chakravarty M; Patel R; Breitner J; Bohbot VD
    J Alzheimers Dis; 2018; 61(4):1493-1507. PubMed ID: 29278888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of White Matter Integrity and Cognitive Functions in Chinese Non-Demented Elderly with the APOE ɛ4 Allele.
    Zhang S; Chen Y; Liu Z; Zhang J; Li X; Cui R; Zhang Z
    J Alzheimers Dis; 2015; 48(3):781-91. PubMed ID: 26402101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    Salami A; Adolfsson R; Andersson M; Blennow K; Lundquist A; Adolfsson AN; Schöll M; Zetterberg H; Nyberg L
    J Alzheimers Dis; 2022; 85(3):1309-1320. PubMed ID: 34924376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential 5-year brain atrophy rates in cognitively declining and stable APOE-ε4 elders.
    Kelly DA; Seidenberg M; Reiter K; Nielson KA; Woodard JL; Smith JC; Durgerian S; Rao SM
    Neuropsychology; 2018 Sep; 32(6):647-653. PubMed ID: 29911873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
    J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precuneus degeneration in nondemented elderly individuals with APOE ɛ4: Evidence from structural and functional MRI analyses.
    Chen Y; Liu Z; Zhang J; Chen K; Yao L; Li X; Gong G; Wang J; Zhang Z
    Hum Brain Mapp; 2017 Jan; 38(1):271-282. PubMed ID: 27593520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Saeed U; Desmarais P; Masellis M
    Expert Rev Neurother; 2021 Aug; 21(8):851-870. PubMed ID: 34311631
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
    Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.
    Seddighi S; Varma VR; An Y; Varma S; Beason-Held LL; Tanaka T; Kitner-Triolo MH; Kraut MA; Davatzikos C; Thambisetty M
    J Alzheimers Dis; 2018; 61(1):401-414. PubMed ID: 29154276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.
    Alexander GE; Bergfield KL; Chen K; Reiman EM; Hanson KD; Lin L; Bandy D; Caselli RJ; Moeller JR
    Neurobiol Aging; 2012 Dec; 33(12):2723-32. PubMed ID: 22405043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.